Methods and compositions for inhibiting CD32B expressing cells

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11434295
APP PUB NO 20120156207A1
SERIAL NO

13294103

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to immunoglobulins that bind FcγRIIb+ cells and coengage the antigen on the cell's surface and an FcγRIIb on the cell's surface, methods for their generation, and methods for using the immunoglobulins.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • XENCOR INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chu, Seung Yup Cypress, US 31 562
Desjarlais, John R Pasadena, US 186 5914
Karki, Sher Bahadur Pomona, US 136 6019
Lazar, Gregory Alan Arcadia, US 155 6953
Moore, Gregory L Monrovia, US 53 1796
Vostiar, Igor Monrovia, US 21 341

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Mar 6, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 6, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 6, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00